References
- Aharoni S, Sadeh M, Shapira Y, Edvardson S, Daana M, Dor-Wollman T, et al. Congenital myasthenic syndrome in Israel: Genetic and clinical characterization. Neuromuscul Disord. 2017; 27(2): 136-140.10.1016/j.nmd.2016.11.01428024842
- Cruz PMR, Palace J, Beeson D. Congenital myasthenic syndromes and the neuromuscular junction. Curr Opin Neurol. 2014; 27(5): 566-575.10.1097/WCO.000000000000013425159927
- Abicht A, Dusl M, Gallenmüller C, Guergueltcheva V, Schara U, Delia Marina A, et al. Congenital myasthenic syndromes: Achievements and limitations of phenotype guided gene after gene sequencing in diagnostic practice: A study of 680 patients. Hum Mutat. 2012; 33(10): 1474-1484.10.1002/humu.22130
- Beeson D. Congenital myasthenic syndromes: Recent advances. Curr Opin Neurol. 2016; 29(5): 565-571.2747250610.1097/WCO.0000000000000370
- Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010; 7(4): 248-249.10.1038/nmeth0410-24820354512
- Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: Mutation prediction for the deep-sequencing age. Nat Methods. 2014; 11(4): 361-362.10.1038/nmeth.289024681721
- Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003; 31(13): 3812-3814.10.1093/nar/gkg50912824425
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17(5): 405-424.2574186810.1038/gim.2015.30
- Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: The NCBI database of genetic variation. Nucleic Acids Res. 2001; 29(1): 308-311.1112512210.1093/nar/29.1.308
- Abecasis GR, Altshuler D, Authon A, Brooks LD, Durbin RM, Gibbs RA; 1000 Genomes Project Consortium, et al. A map of human genome variation from population-scale sequencing. Nature. 2010; 467(7319): 1061-1073.
- Ohno K, Ohkawara B, Ito M. Recent advances in congenital myasthenic syndromes. Clin Exp Neuro-immunol. 2016; 7(3): 246-259.
- McMacken G, Abicht A, Evangelista Τ, Spendiff S, Lochmuller H, Soltanzadeh A. The increasing genetic and phenotypical diversity of congenital myasthenic syndromes. Neuropediatrics. 2017; 48(04): 294-308.2850567010.1055/s-0037-1602832
- Soltanzadeh P, Müller JS, Ghorbani A, Abicht A, Lochmuller H, Soltanzadeh A. An Iranian family with congenital myasthenic syndrome caused by a novel acetylcholine receptor mutation (CHRNE K171X). J Neural Neurosurg Psychiatry. 2005; 76(7): 1039-1040.10.1136/jnnp.2004.059436
- Natera-de Benito D, Dominguez-Carral J, Muelas N, Nascimento A, Ortez C, Jaijo T, et al. Phenotypic heterogeneity in two large Roma families with a congenital myasthenic syndrome due to CHRNE 1267delG mutation. A long-term follow-up. Neuro-muscul Disord. 2016; 26(11): 789-795.
- Richard P, Gaudon K, Haddad H, Ammar AB, Genin E, Bauché S, et al. The CHRNE 1293insG founder mutation is a frequent cause of congenital myasthenia in North Africa. Neurology. 2008; 71(24): 1967-1972.10.1212/01.wnl.0000336921.51639.0b19064877